1 describe a prospective audit of compliance with national guidelines for the empirical therapy of adult patients with bacterial meningitis in The Netherlands. The consensus-based guidelines were developed by a multidisciplinary group of experts in bacterial meningitis. Patients were assigned to one of four categories: age 16-60 years, no risk factors; age Ͼ60 years, no risk factors; age Ͼ16 years with risk factors; age Ͼ16 years, recent neurosurgery. An antibiotic regimen was recommended for patients in each of the categories. The guidelines were disseminated in booklet form and the audit was begun 1 year after they were issued.
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have provided only a few clues to the explanation and have themselves offered only speculation. Could it have been the method used to develop the guidelines? We are given very little information about the development process. Indeed, all we are told is that the guidelines were consensusbased. However, it is not clear whether or not they were also evidence-based and, therefore, scientifically valid. Consequently, individual practitioners may have simply disagreed with the recommendations. For example, 50 (39%) of the 127 patients in the largest group (those 16-60 years of age with no risk factors), who were assigned to be given a penicillin as empirical therapy, actually received a regimen containing a third-generation cephalosporin. This may have been because their clinicians were concerned that they were infected with penicillin-resistant strains of either Streptococcus pneumoniae (even though the incidence of resistance to this antibiotic among pneumococci is only 1.8% in The Netherlands) or other less common bacterial pathogens. The observation that two of the 62 pathogens isolated from patients in this group whose clinicians were compliant with the guidelines were resistant to the recommended regimen, compared with none of the pathogens recovered from patients whose clinicians did not comply with the guidelines, might be seen as justification of these concerns. For this reason, as well as an innate mistrust of national guidelines, a large number of practitioners may have elected to follow their own locally developed antibiotic guidelines.
Alternatively, the explanation may lie in the way the guidelines were disseminated. In the present study, they were distributed in booklet form-a poor means of ensuring that information is read by clinicians without the introduction of one or more other effective measures. Finally, the majority of practitioners may not have adopted the guidelines because of the failure to introduce any interventions to promote their implementation. Any one, or more likely all, of these explanations may have resulted in two out of three clinicians in The Netherlands ignoring national guidelines for the empirical therapy of patients with bacterial meningitis. This study should represent a salutary lesson to those who may be devising clinical guidelines for antibiotic usage (or, indeed, for any other purpose) that if the intended users of the guidelines fail to implement them, their efforts will have been wasted. In the light of the results of this study, and evidence that they are far from unique, as well as a greater trend toward producing guidelines for antibiotic usage, both nationally and locally, in response to increasing concerns about antibiotic resistance, it is timely to review the principles underlying the guideline process.
Clinical guidelines are becoming increasingly popular as a means of influencing clinicians' practice. This is particularly true of guidelines for antibiotic usage. In a survey of consultant microbiologists and hospital pharmacists conducted by a working party of the British Society for Antimicrobial Chemotherapy in 1990, 62% of respondents indicated that antibiotic guidelines were available in their hospitals.
2 More recently, a 1998 survey of hospitals in the USA participating in Project ICARE (Intensive Care Antimicrobial Resistance Epidemiology) showed that 70% of these institutions had introduced clinical guidelines for antibiotic usage. 3 Clinical guidelines have been defined as 'systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances'. 4 They have several aims: to reduce variations in the methods and standards of care; to improve the appropriateness of care; to improve the quality of care; to reduce the costs of care; to improve the cost-effectiveness of care; in the case of antibiotic guidelines, to control, or even reduce, the levels of resistant organisms; to serve as educational tools; and to promote evidence-based decision making. At the very least, they can be regarded as a useful synthesis of current evidence or the consensus of a group of responsible and informed practitioners.
Despite the obvious theoretical benefits arising from the introduction of guidelines, guidelines themselves and the guideline process are fraught with numerous problems and limitations:
• No guideline can be sufficiently specific that it can apply to all clinical situations.
• There is a lack of robust scientific evidence to support many of the recommendations that comprise guidelines.
• Guidelines rarely address co-morbid conditions and concurrent therapy.
• Guidelines fail to take account of patient preferences.
• Until recently there has been little guidance on the methodology of guideline development.
• There is no agreement on the optimal methods of implementing guidelines.
• The costs of developing and implementing guidelines can be considerable.
• Some clinicians perceive that guidelines lead to a loss of autonomy and choice, thereby threatening their clinical freedom.
• Some surveys have raised concerns about the quality of many of the clinical guidelines developed by speciality societies on the grounds that they do not fulfil the basic principles of guideline development; 5,6 the implementation of inappropriate recommendations may lead to inappropriate practices that might compromise patient care.
• There is uncertainty as to whether or not clinical guidelines affect changes in clinical practice and, hence, whether or not the current investment in guideline development is warranted. Some surveys have shown that guidelines have had a limited impact in terms of changing clinical behaviour. [7] [8] [9] [10] [11] [12] [13] [14] Conversely, others have demonstrated that guidelines both lead to improvements in clinical practice and achieve health gains when developed, disseminated and implemented appropriately and when introduced in the context of rigorous evaluation, 15, 16 although the magnitude of improvements in performance have varied widely from study to study.
7,15

Stages of the guideline process
The success of a guideline depends on many factors but, most importantly, the rigour and the commitment used in developing, disseminating, implementing and evaluating it.
Development
A detailed description of the methodology by which guidelines are created is outside the remit of this article. Readers, and particularly those contemplating the development of guidelines, are therefore strongly urged to consult the documents produced by guideline development groups such as SIGN 17 and AGREE, 18 as well as reviews by Thomson et al. 19 and Kish. 20 However, the principal features of guideline development can be summarized as follows:
• The group preparing the guidelines must be multidisciplinary and there must be a sufficient number of members (6-10) with expertise and experience in the subject of the guidelines in order to allow it to be adequately explored 20 and to ensure that the guidelines are credible. The group should comprise at least one individual with the skills necessary to conduct literature and systematic reviews.
• The group should determine whether or not evidencebased guidelines on the same topic already exist. If so, they can be adopted as they are or adapted to suit local circumstances.
• The guidelines must be based on a systematic review of the scientific evidence. In order to minimize the risk of bias, the literature should be identified according to an explicit search strategy, selected according to defined inclusion criteria and assessed against consistent methodological standards. 21 The method by which the literature is obtained, along with the search terms and the period of the search, should be specified.
• As scientifically robust evidence is not always available, it is likely that most guidelines will be a hybrid of varying degrees of evidence and expert opinion. To ensure transparency of the recommendations that comprise the guidelines the recommendations should be graded according to the strength of the evidence supporting them. The grading system should be validated, with the grading based on an objective assessment of the study design and quality and of the consistency, clinical relevance and external validity of the evidence.
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• The guidelines should not be excessively long, i.e. no more than 20-25 pages.
20
• The guideline development group should identify evidence that is lacking and areas for further research.
• The development group should identify sample outcome measures that would form the basis for auditing both the process and outcome of the guidelines.
• The guidelines should be reviewed by respected peers who are not members of the guideline panel, but who are experts in the relevant field.
• Guidelines are not static. They should be reviewed at periodic intervals that should be specified (e.g. 2-yearly), 20 and updated to take account of advances in medical knowledge, changes in clinical practice and local circumstances, and the outcome of guideline evaluations. Any modifications to the guideline must be the result of the same rigour and commitment as the original recommendations.
Dissemination
One reason why guidelines are ineffective is that target clinicians are often not aware of their existence. Dissemination then is the process of bringing guidelines to the attention of their intended users with the aim of increasing awareness and influencing knowledge, attitudes and behaviour.
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Dissemination can be achieved in a variety of ways: publication in journals; newsletters; local reports or documents; junior doctors' handbooks; configuration into a brief and portable format that is readily accessible to clinicians; posters on wards and in relevant departments; patient literature; group educational programmes; and personal visits. The optimal method has not been determined. Publication in medical journals, especially general medical journals, has, to date, been the most commonly used strategy, but is regarded as a poor means of disseminating guidelines with a low likelihood of implementation.
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Direct mailing to relevant practitioners is seen as a more effective measure, but is still of limited efficacy, levels of awareness rarely increasing to Ͼ40%.
7,24 The impact of this intervention can be enhanced by making the guidelines visually attractive and/or by staging their delivery in manageable 'chunks' of information. 25, 26 In general, however, the ability of passive methods such as written communications to achieve even a temporary change in behaviour is questionable. Grimshaw & Russell 23 claimed that the more overtly educational the dissemination strategy the greater the likelihood that guidelines will be adopted and the more lasting their impact, provided that dissemination is linked to an effective implementation strategy.
Implementation
Simply developing and disseminating guidelines, regardless of how well they are done, is of limited value in terms of affecting improvements in health care, unless the guidelines are implemented. Implementation is the process of ensuring that guidelines are introduced into clinical practice. Regrettably, the resources dedicated to developing guidelines have not been matched by those to promote compliance with them and, consequently, there is strong evidence that guidelines are often not adopted. [7] [8] [9] 11, 12, 14 Surveys have shown that compliance can vary from 20% to Ͼ90%, 7,9,11,12,14 depending on the nature of the guideline, the specific clinical problem it is designed to address, the patient group being targeted, the mode of implementation and the definition of adherence. 7,9,11,12,14,27 The most experienced practitioners may be the least likely to comply with guidelines. 27 Several groups of investigators have attempted to determine why rates of compliance with guidelines are so low. Cabana et al. 28 have identified the following barriers to implementation:
• Failure of dissemination strategies to effectively bring the guidelines to the attention of intended users.
• Lack of familiarity with guideline recommendations.
• Lack of agreement with one or more recommendations that comprise the guidelines or the concept of guidelines in general.
• Lack of self-efficacy (due to a lack of confidence in one's ability to perform a behaviour or a lack of preparation).
• Lack of outcome expectancy (i.e. the expectation that a given behaviour will lead to a particular consequence). If a clinician does not believe that implementation of a recommendation will lead to an improved outcome, it is unlikely that the recommendation will be adopted.
• Inability to overcome the inertia of previous views and practice or lack of motivation to change.
• External barriers, including guideline-related barriers (the perception that guidelines are inconvenient or difficult to use), patient-related barriers (an inability to reconcile patient preferences with guideline recommendations) and environment-related barriers (compliance with guidelines may require changes that are outside of clinicians' control, e.g. the need for new or additional resources or facilities such as personnel, equipment, drugs, etc.).
Others have suggested the following additional explanations for practitioners' failure to adhere to guidelines:
• Guidelines may not be written for practising clinicians, but merely represent a summary of the current state of knowledge; 22 in other words, they lack scientific validity.
29-31
• Lack of representation of important stakeholders in the groups that develop guidelines; 5,21,32,33 clinicians may disagree with or distrust guidelines written by national 'experts'.
• Clinicians may choose to ignore guidelines for nonclinical reasons such as financial incentives or fear of litigation.
• Guidelines may lack applicability to individual patients.
15,34
• Failure of local opinion leaders to endorse the guidelines.
29,31,35
• Inefficiencies of the healthcare system.
34,36
Guidelines should facilitate changes in practice, but if the changes are to be sustained, measures designed to promote implementation of guidelines must also change clinicians' knowledge, attitudes and beliefs. 31,37 Active educational interventions, such as seminars that are devoted exclusively to the guidelines and where potential users are given the opportunity to discuss them (following direct mailings of the guidelines as a means of dissemination), are more likely to be effective than didactic lectures or simply including the guidelines as part of an educational programme. 38 However, education alone is insufficient to ensure compliance with clinical guidelines. 39 Other interventions that have been shown in at least some studies to promote adoption of guidelines and to lead to improvements in practice behaviour and clinical outcome include the following:
• Endorsement by local and national professional organizations.
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• Incorporation into routine practice by local 'opinion leaders'.
19,33,40,41
• Dissemination of guidelines by department heads.
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• Audit of compliance with guidelines, with feedback of results to clinicians.
8,19,23
• Peer review.
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• Printed patient-specific reminders at the time of consultations to prompt clinicians to use guidelines, e.g. by attaching the guidelines to clinical notes or by including them on desktop computers.
39,43-47
• General reminders of guidelines.
18,22
• Making guidelines available to practitioners when they are making clinical decisions. This process has been facilitated by computer-assisted decision support programmes such as that developed by Pestotnik et al., 48 although the effects of these systems on patient outcomes
have not yet been adequately assessed.
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• Promoting 'ownership' of guidelines by involving potential users in their development; alternatively, local adaptation of national guidelines may be sufficient to convey a sense of ownership.
• Incorporation of guidelines into service contracts between purchasers and providers.
• 'Academic detailing', i.e. pre-arranged face-to-face discussions between a detailer (a trained educator such as a pharmacist) and a practitioner in the latter's office with the aim of persuading the practitioner to change behaviour through information and evidence. 41 To date, this has been the most effective and most lasting method of promoting compliance [50] [51] [52] [53] and has the advantage of allowing those clinicians who most need to change their practices to be targeted. On the other hand, it is expensive and labour-intensive and concerns have been raised about whether or not it is effective outside the research setting.
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Any one or a combination of measures improves compliance with guidelines to varying degrees. However, because most studies of the efficacies of interventions have involved multiple strategies, it has not been possible to discern from these studies the relative contribution of each measure. For this reason, and because many of the studies suffered from flaws in design and/or execution and because there have been very few comparative studies, efforts to identify the most effective intervention(s) have been frustrated. In general, multiple measures have proved more effective than single interventions, and a combination of strategies is therefore most likely to have the maximum impact on guideline implementation.
Evaluation
Evaluation is the assessment of the efficacy of the guidelines with the aim of ensuring that they have produced the intended changes in both practice and outcome. Audit is the most effective means of doing so, but it is essential to evaluate all of the components of the guideline process, not simply outcome, as they are inextricably linked. In other words, improvements in clinical outcome will not be achieved unless guidelines are received, read and adopted.
National versus local guidelines
Guidelines can be developed nationally or locally. Those developed locally (or internally) by the clinicians who will use them are less likely to be scientifically valid than those developed nationally by Royal Colleges and working parties of speciality societies 54,55 because local groups lack the clinical, managerial and technical skills, as well as the time and financial resources, needed for the task. 23 Moreover, expertise at the local level is unlikely to be sufficiently broad and personal opinions may influence conclusions.
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Locally produced guidelines must be no less robust than those produced nationally if patients are to receive optimal care. On the other hand, clinicians may disagree with or distrust guidelines written by remote national 'experts'. It has been claimed that '…medical practices are locally driven, and national guidelines simply do not reflect or determine the systems of care and patterns of practice in the individual hospitals. Experience has demonstrated that national guidelines are seldom studied thoroughly by physicians, and if they are read, they are rarely incorporated into everyday practice'; 57 this view has also been expressed by others.
7,15,32,58-60 Guidelines are more likely to be adopted if users have participated in their development. 23 Consequently, fewer resources are needed for effective dissemination and to promote implementation, compared with national guidelines for which greater emphasis must be placed on these phases of the process. A reasonable compromise would be to adapt national evidence-based guidelines (where such guidelines exist) for local use, a strategy that may be adequate to ensure clinicians' compliance. 
